What are Ampio Pharmaceuticals Inc's key financial statements?

According to the latest financial statement (Form-10K), Ampio Pharmaceuticals Inc has a total asset of $0, Net loss of $0

What are the key financial ratios for AMPE?

Ampio Pharmaceuticals Inc's Current ratio is 0, has a Net margin is 0, sales per share of $0.

How is Ampio Pharmaceuticals Inc's revenue broken down by segment or geography?

Currently Ampio Pharmaceuticals Inc data is not available.

Is Ampio Pharmaceuticals Inc profitable?

no, according to the latest financial statements, Ampio Pharmaceuticals Inc has a net loss of $0

Does Ampio Pharmaceuticals Inc have any liabilities?

no, Ampio Pharmaceuticals Inc has liability of 0

How many outstanding shares for Ampio Pharmaceuticals Inc?

Ampio Pharmaceuticals Inc has a total outstanding shares of 0

AMPE Financials: Ampio Pharmaceuticals Inc AI Analysis



Financials

AMPE Financial

Ampio Pharmaceuticals Inc

0%

$0

At close: May 12, 16:00:00 GMT-4

0%

$0

Pre-market: May 13, 05:43:29 GMT-4

Overview Forecast Earnings Dividends Financials

Key Stats

Prev.Close

Open

Day's Range

52 week range

Volume

Avg.Volume

Dividend yield

EPS (TTM)

Market Cap

What is AMPE?

Ampio Pharmaceuticals, Inc. operates as a biopharmaceutical company. The company is headquartered in Englewood, Colorado and currently employs 6 full-time employees. The company went IPO on 2011-05-19. The firm is focused on combining scientific, clinical, and manufacturing capabilities to develop therapies aimed at treating conditions for which limited treatment options exist.

Features

Markets

News

Breakdown	TTM	12/31/2023	09/30/2023	06/30/2023	03/31/2023	12/31/2022
Revenue	0	0	0	0	0	0
Revenue Growth (YoY)	--	--	--	--	--	--
Cost of Revenue	--	--	--	--	--	--
Gross Profit	--	--	--	--	--	--
Selling, General & Admin	7	0	1	1	3	1
Research & Development	2	1	0	0	0	0
Operating Expenses	9	2	1	1	4	2
Other Non Operating Income (Expenses)	0	0	0	0	0	--
Pretax Income	-8	-2	-1	-1	-3	-2
Income Tax Expense	--	--	--	--	--	--
Net Income	-8	-2	-1	-1	-3	-2
Net Income Growth	-50%	0%	-83%	-50%	-40%	-67%
Shares Outstanding (Diluted)	0.82	0.82	0.8	0.75	0.75	0.75
Shares Change (YoY)	10%	10%	7%	0%	0%	10%
EPS (Diluted)	-10.42	-2.48	-1.52	-1.82	-5.3	-2.95
EPS Growth	-52%	-16%	-82%	-34%	-30%	-68%
Free Cash Flow	-8	-2	0	-3	-2	-4
Free Cash Flow Per Share	--	--	--	--	--	--
Gross Margin	--	--	--	--	--	--
Operating Margin	0%	0%	0%	0%	0%	0%
Profit Margin	0%	0%	0%	0%	0%	0%
Free Cash Flow Margin	0%	0%	0%	0%	0%	0%
EBITDA	-9	-2	-1	-1	-4	-2
EBITDA Margin	0%	0%	0%	0%	0%	0%
D&A For EBITDA	0	0	0	0	0	0
EBIT	-9	-2	-1	-1	-4	-2
EBIT Margin	0%	0%	0%	0%	0%	0%
Effective Tax Rate	--	--	--	--	--	--

Ampio Pharmaceuticals Inc (AMPE) Financial

AMPE Stock Price Chart

Key Stats

Prev.Close

Open

Day's Range

52 week range

Volume

Avg.Volume

Dividend yield

EPS (TTM)

Market Cap

What is AMPE?

Ampio Pharmaceuticals Inc (AMPE) Financial

AMPE Stock Price Chart

Key Stats

Prev.Close

Open

Day's Range

52 week range

Volume

Avg.Volume

Dividend yield

EPS (TTM)

Market Cap

What is AMPE?

AMPE Income

Follow-Up Questions

What are Ampio Pharmaceuticals Inc's key financial statements?

What are the key financial ratios for AMPE?

How is Ampio Pharmaceuticals Inc's revenue broken down by segment or geography?

Is Ampio Pharmaceuticals Inc profitable?

Does Ampio Pharmaceuticals Inc have any liabilities?

How many outstanding shares for Ampio Pharmaceuticals Inc?